NDC 16729-289

Buspirone Hydrochloride 30 mg tablet

On the label: Accord Healthcare Inc..

Where it's made

Recalls

• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: P2105532, Exp. Date 6/30/2024; P2200348, Exp. Date 12/31/2024;
• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: a) P2200530, Exp. Date 12/31/2024; b) P2105583, Exp. Date 6/30/2024;
• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: P2105483, Exp. Date 7/31/2024;
• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: P2105472, Exp. Date 4/30/2024;
• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: P2105551, Exp. Date 7/31/2024;

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Buspirone: every company that makes it

Form

tablet, oral

Strength

30 mg

Approval

ANDA ANDA202557

On the market since

Dec 15, 2016

Package NDCs

16729-289-01 16729-289-12 16729-289-16 16729-289-17 16729-289-59

Official label

DailyMed (National Library of Medicine), updated Oct 7, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?